Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in de novo large B-cell lymphoma and transformed low-grade B-cell lymphoma.

Autor: Benjamini O; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv. ohad.benjamini@sheba.health.gov.il., Fried S; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Shouval R; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Flynn JR; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York., Beyar-Katz O; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa., Leslie LA; John Theurer Cancer Center, Hackensack, University Medical Center, Hackensack New Jersey., Zucherman T; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa., Yerushalmi R; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Shem-Tov N; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Palomba ML; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Danylesko I; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Sdayoor I; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Malka H; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa., Itzhaki O; Ella Lemelbaum Institute for Immuno Oncology, Chaim Sheba Medical Center, Hashomer., Suh H; John Theurer Cancer Center, Hackensack, University Medical Center, Hackensack New Jersey., Devlin SM; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York., Marcus R; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Dahi PB; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Jacoby E; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv, Israel; Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Chaim Sheba Medical Center, Hashomer., Shah GL; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York., Sauter CS; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH., Ip A; John Theurer Cancer Center, Hackensack, University Medical Center, Hackensack New Jersey, United States; Hackensack Meridian School of Medicine, Nutley, NJ., Perales MA; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Nagler A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Shimoni A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Scordo M; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Avigdor A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv.

Publikováno v: Haematologica [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3566-3577. Date of Electronic Publication: 2024 Nov 01.